Seeking People with Post-Traumatic Stress Disorder (PTSD)
to Participate in a Psilocybin Clinical Trial

Researchers at the Johns Hopkins Center for Psychedelic & Consciousness Research are seeking individuals with post-traumatic stress disorder (PTSD) to participate in a clinical trial of psilocybin, a psychoactive substance found in naturally occurring mushrooms. The study will investigate the effects of psilocybin treatment on PTSD symptoms.

Volunteers must be between the ages of 21 and 75, have a diagnosis of PTSD with symptom duration of six months or greater, be currently taking a serotonin reuptake inhibitor (e.g., SSRI or SNRI), and have no recent history of substance abuse.

Principal Investigator: Sandeep Nayak, M.D.
Co-Investigator: Brandon Weiss, Ph.D.

Application Number: IRB00407008

Please click "Next" below to complete the initial screening survey to see if you may qualify for the study.